1
|
Duan J, Cao Y, Xie H, Yu Y, Sheng H, Kong W, Li T. Synthesis of 2-Phosphonylated C3 Spirocyclic Indolines via a Dearomatization-Spirocyclization-Nucleophilic Addition Tandem Approach of Indolyl-ynones with Phosphine Oxides. J Org Chem 2025; 90:428-438. [PMID: 39693453 DOI: 10.1021/acs.joc.4c02364] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2024]
Abstract
Due to its unique three-dimensional (3D) configuration and great application potential in medicinal chemistry and synthetic community, chemists have been pursuing concise and efficient methods to synthesize C3 spirocyclic indoline derivatives. In this work, a dearomatization-spirocyclization-nucleophilic addition tandem approach was developed to realize the synthesis of 2-phosphonylated C3 spirocyclic indolines with indolyl-ynones and phosphine oxides as reactants; mild conditions, broad substrate scope, and good yields are characteristics of this transformation.
Collapse
Affiliation(s)
- Jiongjiong Duan
- College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang 473061, People's Republic of China
| | - Yi Cao
- College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang 473061, People's Republic of China
| | - Huanping Xie
- College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang 473061, People's Republic of China
| | - Yongqi Yu
- College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang 473061, People's Republic of China
| | - Heyun Sheng
- College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang 473061, People's Republic of China
| | - Weiguang Kong
- College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang 473061, People's Republic of China
| | - Ting Li
- College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang 473061, People's Republic of China
| |
Collapse
|
2
|
Zhou Z, Huang X, Wei QY, Wang YL, Wu B, Yang JM. Access to Piperazine-Fused Pyrrolocarbazoles Enabled by Acid-Catalyzed Stereoselective Hydroarylation of Ynamide-Indoles and Subsequent Diels-Alder Reactions/Aromatizations. Org Lett 2024; 26:7273-7278. [PMID: 39133635 DOI: 10.1021/acs.orglett.4c01889] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/16/2024]
Abstract
Pyrrolocarbazole skeletons are well known to possess a variety of biological activities that might be therapeutically useful in the treatment of cancers. Herein, an acid-catalyzed stereoselective hydroarylation/Diels-Alder cycloaddition/aromatization of ynamide-indoles is described. We newly designed and synthesized a variety of piperazine-fused pyrrolocarbazole derivatives that could be further applied to the synthesis of potent Wee1 inhibitors.
Collapse
Affiliation(s)
- Ze Zhou
- School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan 430074, People's Republic of China
| | - Xiang Huang
- School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan 430074, People's Republic of China
| | - Qing-Yi Wei
- School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan 430074, People's Republic of China
| | - Yi-Lin Wang
- School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan 430074, People's Republic of China
| | - Bin Wu
- School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan 430074, People's Republic of China
| | - Jin-Ming Yang
- School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan 430074, People's Republic of China
| |
Collapse
|
3
|
Shen W, Lu X, Shen Y, Li J, Jia A, Tang S. Synthesis of Azepino[4,5- b]indole via Ring Expansion of Tetrahydro-β-carbolines Ammonium Ylide. J Org Chem 2023. [PMID: 38156631 DOI: 10.1021/acs.joc.3c02249] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2024]
Abstract
The formal cyclization strategy was generally used to construct azepino[4,5-b]indole. Herein, we reported a novel and expeditious protocol for the synthesis of quaternary carbon azepino[4,5-b]indole via ring expansion of ammonium ylide, which was formed by the reaction of tetrahydro-β-carbolines with the diazo compound. The easily available substrates, mild reaction conditions, and broad functional tolerance rendered this method a practical strategy that may significantly afford an efficient method of scaffold hopping in drug discovery.
Collapse
Affiliation(s)
- Wang Shen
- Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, P. R. China
| | - Xiyao Lu
- Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, P. R. China
| | - Yu Shen
- Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, P. R. China
| | - Junjian Li
- Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, P. R. China
| | - Aiqun Jia
- Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou 570311, P. R. China
| | - Shi Tang
- Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, P. R. China
| |
Collapse
|
4
|
Yang L, Hou A, Jiang Q, Cheng M, Liu Y. Methodological Development and Applications of Tryptamine-Ynamide Cyclizations in Synthesizing Core Skeletons of Indole Alkaloids. J Org Chem 2023; 88:11377-11391. [PMID: 37540141 DOI: 10.1021/acs.joc.3c01088] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/05/2023]
Abstract
Over the past two decades, synthetic strategies for synthesizing the skeletons of various indole alkaloids based on tryptamine-ynamide have been continuously developed and applied to the total syntheses or formal total syntheses of related molecules. In this synopsis, we summarized the cyclization pathways of tryptamine-ynamide under different catalytic conditions, emphasizing the reaction mechanism and applications in the syntheses of indole alkaloids.
Collapse
Affiliation(s)
- Lu Yang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Anbin Hou
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Qing Jiang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Maosheng Cheng
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Yongxiang Liu
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| |
Collapse
|
5
|
Zhu J, Li J, Zhang L, Sun S, Yang L, Fu J, Sun H, Cheng M, Lin B, Liu Y. Gold(I)-Catalyzed Substitution-Controlled Syntheses of Spiro[indoline-3,3 '-pyrrolidine] and Spiro[indoline-3,3 '-piperidine] Derivatives. J Org Chem 2023. [PMID: 37449800 DOI: 10.1021/acs.joc.3c00604] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/18/2023]
Abstract
Spiro[indoline-3,3'-pyrrolidine] and spiro[indoline-3,3'-piperidine] derivatives were synthesized in a substitution-controlled manner under the catalysis of cationic gold(I) species in the presence of Hantzsch ester (HEH). The optimal reaction condition was determined by screening, and the functional group tolerances of these two pathways were examined by readily synthetic substrates. The endo and exo selectivities of these cyclizations were elucidated by density functional theory calculations, and a plausible mechanism for these transformations was proposed.
Collapse
Affiliation(s)
- Jiang Zhu
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Jiaji Li
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Lianjie Zhang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Shitao Sun
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Lu Yang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Jiayue Fu
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Hanyang Sun
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Maosheng Cheng
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Bin Lin
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Yongxiang Liu
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| |
Collapse
|
6
|
Sun Z, Zhang X, Fu J, Zhang L, Cheng M, Yang L, Liu Y. Collective Syntheses of 8-Oxoprotoberberines via Sequential In(OTf) 3-Catalyzed Cyclization and Pd(OAc) 2-Catalyzed Heck Coupling. J Org Chem 2023. [PMID: 37172220 DOI: 10.1021/acs.joc.3c00419] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/14/2023]
Abstract
Six 8-oxoprotoberberines were synthesized collectively in four steps with acceptable yields (14-19%), of which the products 8-oxopalmatine, 8-oxopseudopalmatine, 8-oxoberberine, and 8-oxopseudoberberine come from nature. The synthetic route was featured with the In(OTf)3-catalyzed cyclization and Heck coupling. Moreover, the syntheses of the natural products berberine, canadine, and iambertine were achieved via various reductions from 8-oxoberberine, which provided a concise approach to the syntheses of this kind of alkaloids.
Collapse
Affiliation(s)
- Zenghui Sun
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Xinhang Zhang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Jiayue Fu
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Lianjie Zhang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Maosheng Cheng
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Lu Yang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Yongxiang Liu
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| |
Collapse
|
7
|
Zhu J, Li J, Zhang L, Sun S, Wang Z, Li X, Yang L, Cheng M, Lin B, Liu Y. Quantum Mechanical Prediction and Experimental Verification of Au(I)-Catalyzed Substitution-Controlled Syntheses of 1 H-Pyrido[4,3- b]indole and Spiro[indoline-3,3'-pyridine] Derivatives. J Org Chem 2023; 88:5483-5496. [PMID: 37043684 DOI: 10.1021/acs.joc.2c03104] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/14/2023]
Abstract
Density functional theory calculations were applied to predict the pathways of gold(I)-catalyzed cycloisomerization of the indole substrates with 1,6-enynes, which were consistent with the ensuing experimental results. The substitution-controlled synthesis led to the formation of 1H-pyrido[4,3-b]indole and spiro[indoline-3,3'-pyridine] derivatives in a tunable way. The reactions had good functional group tolerances, and a possible mechanism was proposed based on the computational and experimental results.
Collapse
Affiliation(s)
- Jiang Zhu
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Jiaji Li
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Lianjie Zhang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Shitao Sun
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Zhaobo Wang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Xiang Li
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Lu Yang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Maosheng Cheng
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Bin Lin
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Yongxiang Liu
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| |
Collapse
|
8
|
Sun S, Hao J, Cheng M, Liu Y, Lin B. Computational insight into gold(I)-catalyzed intramolecular regioselectivity of tryptamine-ynamide cycloisomerizations. Org Biomol Chem 2023; 21:2610-2619. [PMID: 36896738 DOI: 10.1039/d3ob00079f] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/05/2023]
Abstract
The regioselectivity for gold(I)-catalyzed intramolecular cycloisomerizations of tryptamine-ynamides has long been elusive despite various synthetic examples of similar substrates being available. Computational studies were carried out to provide insight into the mechanisms and the origin of the substrate-dependent regioselectivity of these transformations. Based on the analyses of non-covalent interactions, distortion/interaction, and energy decomposition on the interactions between the terminal substituent of alkynes and the gold(I) catalytic ligand, the electrostatic effect was determined to be the key factor for α-position selectivity while the dispersion effect was determined to be the key factor for β-position selectivity. Our computational results were consistent with the experimental observations. This study provides useful guidance for understanding other similar gold(I)-catalyzed asymmetric alkyne cyclization reactions.
Collapse
Affiliation(s)
- Shitao Sun
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
| | - Jinle Hao
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
| | - Maosheng Cheng
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.
| | - Yongxiang Liu
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
| | - Bin Lin
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
| |
Collapse
|
9
|
Zhu BH, Ye SB, Nie ML, Xie ZY, Wang YB, Qian PC, Sun Q, Ye LW, Li L. I 2 -Catalyzed Cycloisomerization of Ynamides: Chemoselective and Divergent Access to Indole Derivatives. Angew Chem Int Ed Engl 2023; 62:e202215616. [PMID: 36573021 DOI: 10.1002/anie.202215616] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2022] [Indexed: 12/28/2022]
Abstract
Herein, an I2 -catalyzed unprecedented cycloisomerization of ynamides is developed, furnishing various functionalized bis(indole) derivatives in generally good to excellent yields with wide substrate scope and excellent atom-economy. This protocol not only represents the first molecular-iodine-catalyzed tandem complex alkyne cycloisomerizations, but also constitutes the first chemoselective cycloisomerization of tryptamine-ynamides involving distinctively different C(sp3 )-C(sp3 ) bond cleavage and rearrangement. Moreover, chiral tetrahydropyridine frameworks containing two stereocenters are obtained with moderate to excellent diastereoselectivities and excellent enantioselectivities. Meanwhile, cycloisomerization and aromatization of ynamides produce pyrrolyl indoles with high efficiency enabled by I2 . Additionally, control experiments and theoretical calculations reveal that this reaction probably undergoes a tandem 5-exo-dig cyclization/rearrangement process.
Collapse
Affiliation(s)
- Bo-Han Zhu
- College of Chemistry & Materials Engineering, Wenzhou University, Wenzhou, 325035, China.,Wenzhou Key Laboratory of Technology and Application of Environmental Functional Materials, Institute of New Materials & Industry Technology, Wenzhou University, Wenzhou, 325000, China
| | - Sheng-Bing Ye
- College of Chemistry & Materials Engineering, Wenzhou University, Wenzhou, 325035, China.,Wenzhou Key Laboratory of Technology and Application of Environmental Functional Materials, Institute of New Materials & Industry Technology, Wenzhou University, Wenzhou, 325000, China
| | - Min-Ling Nie
- College of Chemistry & Materials Engineering, Wenzhou University, Wenzhou, 325035, China.,Wenzhou Key Laboratory of Technology and Application of Environmental Functional Materials, Institute of New Materials & Industry Technology, Wenzhou University, Wenzhou, 325000, China
| | - Zhong-Yang Xie
- College of Chemistry & Materials Engineering, Wenzhou University, Wenzhou, 325035, China.,Wenzhou Key Laboratory of Technology and Application of Environmental Functional Materials, Institute of New Materials & Industry Technology, Wenzhou University, Wenzhou, 325000, China
| | - Yi-Bo Wang
- College of Chemistry & Materials Engineering, Wenzhou University, Wenzhou, 325035, China.,Wenzhou Key Laboratory of Technology and Application of Environmental Functional Materials, Institute of New Materials & Industry Technology, Wenzhou University, Wenzhou, 325000, China
| | - Peng-Cheng Qian
- College of Chemistry & Materials Engineering, Wenzhou University, Wenzhou, 325035, China.,Wenzhou Key Laboratory of Technology and Application of Environmental Functional Materials, Institute of New Materials & Industry Technology, Wenzhou University, Wenzhou, 325000, China
| | - Qing Sun
- Key Laboratory of Jiangxi Province for Persistent Pollutants Control and Resources Recycle, Nanchang Hangkong University, Nanchang, 330063, China
| | - Long-Wu Ye
- State Key Laboratory of Physical Chemistry of Solid Surfaces and College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, 361005, China
| | - Long Li
- College of Chemistry & Materials Engineering, Wenzhou University, Wenzhou, 325035, China.,Wenzhou Key Laboratory of Technology and Application of Environmental Functional Materials, Institute of New Materials & Industry Technology, Wenzhou University, Wenzhou, 325000, China.,State Key Laboratory of Physical Chemistry of Solid Surfaces and College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, 361005, China
| |
Collapse
|
10
|
Chen Y, Wang Z, Zhao W, Sun S, Yang L, Zhang J, Zhang D, Cheng M, Lin B, Liu Y. Ag(I)/PPh 3-catalyzed diastereoselective syntheses of spiro[indole-3,4'-piperidine] derivatives via cycloisomerizations of tryptamine-ynamides. Chem Commun (Camb) 2022; 58:3051-3054. [PMID: 35165679 DOI: 10.1039/d1cc07298f] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
A Ag(I)/PPh3-catalyzed chelation-controlled cycloisomerization of tryptamine-ynamide was developed to access the spiro[indole-3,4'-piperidine] scaffold in a racemic and diastereoselective manner. The diastereoselective products were achieved by a chiron approach. Density functional theory (DFT) calculations indicated that strong non-covalent effects between the substrate and catalyst/ligand complex stabilized the spiroindoleninium intermediate via cation-π-π interactions.
Collapse
Affiliation(s)
- Yanyu Chen
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China. .,Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Zhaobo Wang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China. .,Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Wutong Zhao
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.
| | - Shitao Sun
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China. .,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Lu Yang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China. .,Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Junpeng Zhang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China. .,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Di Zhang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China. .,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Maosheng Cheng
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China. .,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Bin Lin
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China. .,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Yongxiang Liu
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China. .,Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| |
Collapse
|
11
|
Xie F, Li X, Xu L, Ma J, Sun L, Zhang B, Lin B, Cheng M, Liu Y. Diels‐Alder Cycloaddition of Azepino[4,5‐b]indoles towards Hydrocarbazole Derivatives and Related Heterocycles. Adv Synth Catal 2022. [DOI: 10.1002/adsc.202101401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- Fukai Xie
- Shenyang Pharmaceutical University CHINA
| | - Xiang Li
- Shenyang Pharmaceutical University CHINA
| | - Liangyu Xu
- Shenyang Pharmaceutical University CHINA
| | - Jun Ma
- Shenyang Pharmaceutical University CHINA
| | - Lei Sun
- Shenyang Pharmaceutical University CHINA
| | - Bo Zhang
- Shenyang Pharmaceutical University CHINA
| | - Bin Lin
- Shenyang Pharmaceutical University CHINA
| | | | | |
Collapse
|
12
|
Lin X, Zhao C, Wang D, Wu G, Chen G, Chen S, Ren H, Deng D, Xu Y, Hu X, Liu Y. BiCl
3
‐Mediated Tandem Cyclization of Tryptamine‐Derived Ynamide: Concise Synthesis of Pentacyclic Spiroindolines and Tricyclic Indole Derivatives. Adv Synth Catal 2021. [DOI: 10.1002/adsc.202101232] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Affiliation(s)
- Xiao‐Tong Lin
- School of Chemistry and Chemical Engineering Guangzhou University 230 Wai Huan Xi Road, Guangzhou Higher Education Mega Center Guangzhou 510006 People's Republic of China
| | - Cheng Zhao
- School of Chemistry and Chemical Engineering Guangzhou University 230 Wai Huan Xi Road, Guangzhou Higher Education Mega Center Guangzhou 510006 People's Republic of China
| | - Da‐Ru Wang
- School of Chemistry and Chemical Engineering Guangzhou University 230 Wai Huan Xi Road, Guangzhou Higher Education Mega Center Guangzhou 510006 People's Republic of China
| | - Guang‐Cheng Wu
- School of Chemistry and Chemical Engineering Guangzhou University 230 Wai Huan Xi Road, Guangzhou Higher Education Mega Center Guangzhou 510006 People's Republic of China
| | - Guo‐Shu Chen
- School of Chemistry and Chemical Engineering Guangzhou University 230 Wai Huan Xi Road, Guangzhou Higher Education Mega Center Guangzhou 510006 People's Republic of China
| | - Shu‐Jie Chen
- School of Chemistry and Chemical Engineering Guangzhou University 230 Wai Huan Xi Road, Guangzhou Higher Education Mega Center Guangzhou 510006 People's Republic of China
| | - Hai Ren
- State Key Laboratory of Functions and Applications of Medicinal Plants Guizhou Medical University Guiyang 550014 People's Republic of China
| | - Dong‐Sheng Deng
- College of Chemistry and Chemical Engineering Luoyang Normal University Luoyang 471934 People's Republic of China
| | - Yi‐Bing Xu
- School of Chemistry and Chemical Engineering Guangzhou University 230 Wai Huan Xi Road, Guangzhou Higher Education Mega Center Guangzhou 510006 People's Republic of China
| | - Xiao‐Wei Hu
- School of Chemistry and Chemical Engineering Guangzhou University 230 Wai Huan Xi Road, Guangzhou Higher Education Mega Center Guangzhou 510006 People's Republic of China
| | - Yun‐Lin Liu
- School of Chemistry and Chemical Engineering Guangzhou University 230 Wai Huan Xi Road, Guangzhou Higher Education Mega Center Guangzhou 510006 People's Republic of China
- State Key Laboratory of Functions and Applications of Medicinal Plants Guizhou Medical University Guiyang 550014 People's Republic of China
- Guangdong Provincial Key Laboratory of Catalysis Southern University of Science and Technology Shenzhen 518055 People's Republic of China
| |
Collapse
|
13
|
Yang L, Huang S, Huang R, Hou A, Zhang S, Su H, Ding X, Lin B, Cheng M, Liu Y. Total Syntheses of Aspidospermidine, N-Methylaspidospermidine, N-Acetylaspidospermidine, and Aspidospermine via a Tandem Cyclization of Tryptamine-Ynamide. Org Lett 2021; 23:6471-6476. [PMID: 34339196 DOI: 10.1021/acs.orglett.1c02287] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
The total syntheses of aspidospermidine, N-methylaspidospermidine, N-acetylaspidospermidine, and aspidospermine were achieved from a common pentacyclic indoline intermediate. The common pentacyclic indoline intermediate was synthesized on a gram scale through a Stork-enamine alkylation of 1H-pyrrolo[2,3-d]carbazole derivatives, which were prepared through a Brønsted acid-catalyzed tandem cyclization of tryptamine-ynamide. The scalable synthesis of 1H-pyrrolo[2,3-d]carbazole afforded facile access and a practical approach to the Aspidosperma indole alkaloid family.
Collapse
Affiliation(s)
- Lu Yang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Siwen Huang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Rongkang Huang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Anbin Hou
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Sen Zhang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Hongwei Su
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Xiaohong Ding
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Bin Lin
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Maosheng Cheng
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Yongxiang Liu
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| |
Collapse
|
14
|
Bag D, Sawant SD. Heteroarene-tethered Functionalized Alkyne Metamorphosis. Chemistry 2021; 27:1165-1218. [PMID: 32603015 DOI: 10.1002/chem.202002154] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2020] [Indexed: 12/11/2022]
Abstract
Heteroarene-tethered functionalized alkynes are multipotent synthons in organic chemistry. This detailed Review described herein offers a thorough discussion of the metamorphosis of heteroarene-tethered functionalized alkynes, an area which has earned much attention over the past decade in the straightforward synthesis of architecturally complex heterocyclic scaffolds in atom and step economic manner. Depending upon the variety of functionalized alkynes, this Review is divided into multiple sections. Amongst the vast array of synthetic transformations covered, dearomatizing spirocyclizations and cascade spirocyclization/rearrangement are of great interest. Synthetic transformations involving the heteroarene-tethered functionalized alkynes with scope, challenges, limitations, mechanism, their application in the total synthesis of natural products and future perceptions are surveyed.
Collapse
Affiliation(s)
- Debojyoti Bag
- Laboratory 212, Medicinal Chemistry Division, CSIR-Indian Institute of Integrative Medicine Jammu, Canal Road, Jammu, Jammu and Kashmir, 180001, India
| | - Sanghapal D Sawant
- Laboratory 212, Medicinal Chemistry Division, CSIR-Indian Institute of Integrative Medicine Jammu, Canal Road, Jammu, Jammu and Kashmir, 180001, India
| |
Collapse
|
15
|
Xi S, Dong J, Chen H, Dong Q, Yang J, Tan Q, Zhang C, Lan Y, Zhang M. Lewis acid-catalyzed domino generation/[2,3]-sigmatropic rearrangement of ammonium ylides to access chiral azabicycles. SCIENCE ADVANCES 2021; 7:eabd5290. [PMID: 33514546 PMCID: PMC7846163 DOI: 10.1126/sciadv.abd5290] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/26/2020] [Accepted: 12/11/2020] [Indexed: 06/12/2023]
Abstract
[2,3]-Sigmatropic rearrangement of ammonium ylides represents a fundamental reaction for stereoselective synthesis of nitrogenous compounds. However, its applicability is limited by the scarcity of efficient, catalytic, and mild methods for generating ammonium ylides. Here, we report silver-catalyzed domino generation/[2,3]-sigmatropic rearrangement of ammonium ylides, furnishing chiral azabicycles with bridgehead quaternary stereogenic centers in high enantiomeric purity (up to 99% ee). A combination of density functional theory calculations and experimental studies revealed that residual water in the reaction system is crucial for the mild reaction conditions by functioning as a proton shuttle to assist carbon-silver bond protonation and C2─H deprotonation to generate the ammonium ylide. This reaction has a broad application scope. Besides the diverse substituents, N-fused azabicycles of various ring sizes are also easily accessed. In addition to silver salts, this strategy has also been successfully implemented by using a stoichiometric amount of nonmetallic I2.
Collapse
Affiliation(s)
- Song Xi
- Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing, China
| | - Jiawei Dong
- Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing, China
| | - Haohua Chen
- Chongqing Key Laboratory of Theoretical and Computational Chemistry, School of Chemistry and Chemical Engineering, Chongqing University, Chongqing, China
| | - Qiuyan Dong
- Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing, China
| | - Jiao Yang
- Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing, China
| | - Qiuyuan Tan
- Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing, China
| | - Changhui Zhang
- Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing, China
| | - Yu Lan
- Chongqing Key Laboratory of Theoretical and Computational Chemistry, School of Chemistry and Chemical Engineering, Chongqing University, Chongqing, China.
- Green Catalysis Center, College of Chemistry, Zhengzhou University, Zhengzhou, China
| | - Min Zhang
- Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing, China.
- Chongqing Key Laboratory of Theoretical and Computational Chemistry, School of Chemistry and Chemical Engineering, Chongqing University, Chongqing, China
- State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, China
| |
Collapse
|
16
|
Sun Y, Feng C, Wang P, Yang F, Wu Y. Cobalt-catalyzed C8–H sulfonylation of 1-naphthylamine derivatives with sodium sulfinates. Org Chem Front 2021. [DOI: 10.1039/d1qo00975c] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
A facile and efficient protocol for cobalt-catalyzed regioselective C8–H sulfonylation of 1-naphthylamine derivatives with sodium sulfinates was developed to afford sulfonylated naphthylamines in moderate to good yields.
Collapse
Affiliation(s)
- Yucong Sun
- College of Chemistry, Green Catalysis Center, Henan Key Laboratory of Chemical Biology and Organic Chemistry, Key Laboratory of Applied Chemistry of Henan Universities, Zhengzhou University, Zhengzhou 450052, P R China
| | - Cancan Feng
- College of Chemistry, Green Catalysis Center, Henan Key Laboratory of Chemical Biology and Organic Chemistry, Key Laboratory of Applied Chemistry of Henan Universities, Zhengzhou University, Zhengzhou 450052, P R China
| | - Peisong Wang
- College of Chemistry, Green Catalysis Center, Henan Key Laboratory of Chemical Biology and Organic Chemistry, Key Laboratory of Applied Chemistry of Henan Universities, Zhengzhou University, Zhengzhou 450052, P R China
| | - Fan Yang
- College of Chemistry, Green Catalysis Center, Henan Key Laboratory of Chemical Biology and Organic Chemistry, Key Laboratory of Applied Chemistry of Henan Universities, Zhengzhou University, Zhengzhou 450052, P R China
| | - Yangjie Wu
- College of Chemistry, Green Catalysis Center, Henan Key Laboratory of Chemical Biology and Organic Chemistry, Key Laboratory of Applied Chemistry of Henan Universities, Zhengzhou University, Zhengzhou 450052, P R China
| |
Collapse
|
17
|
Sushmita, Aggarwal T, Kumar S, Verma AK. Exploring the behavior of the NFSI reagent as a nitrogen source. Org Biomol Chem 2020; 18:7056-7073. [PMID: 32909593 DOI: 10.1039/d0ob01429j] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/25/2024]
Abstract
The diverse biological activities of nitrogen-containing compounds make the construction of the C-N bond of great importance. As N-fluorobenzenesulfonimide, one of the most abundant chemical feedstock, has a dual behaviour, i.e. as an electrophilic fluorination and amidation source, it attracts the attention of synthetic chemists for exploitation. This review comprehensively summarizes the significant progress of the efficient and mild amidation reactions, with an emphasis on approaches for the generation of nitrogen-centered intermediates, related mechanisms and new synthetic chemistry methods that offer opportunities to overcome obstacles in pharmaceutical applications. In this perspective, we discuss the developments in the amidation reaction using NFSI in the past decade. We discuss the recent progress, challenges and future outcomes in the area of amidation chemistry using commercially available NFSI.
Collapse
Affiliation(s)
- Sushmita
- Synthetic Organic Chemistry Laboratory, Department of Chemistry, University of Delhi, Delhi-110007, India.
| | - Trapti Aggarwal
- Synthetic Organic Chemistry Laboratory, Department of Chemistry, University of Delhi, Delhi-110007, India.
| | - Sonu Kumar
- Synthetic Organic Chemistry Laboratory, Department of Chemistry, University of Delhi, Delhi-110007, India.
| | - Akhilesh K Verma
- Synthetic Organic Chemistry Laboratory, Department of Chemistry, University of Delhi, Delhi-110007, India.
| |
Collapse
|
18
|
Liang G, Pang Y, Ji Y, Zhuang K, Li L, Xie F, Yang L, Cheng M, Lin B, Liu Y. Diastereoselective Syntheses of Spiro[indoline-3,4′-pyridin]-2-yl Carbamates via AgOTf/Ph3P-Catalyzed Tandem Cyclizations of Tryptamine-Ynesulfonamides. J Org Chem 2020; 85:3010-3019. [DOI: 10.1021/acs.joc.9b02839] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Guoduan Liang
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Yadong Pang
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Yanjun Ji
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Kaitong Zhuang
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Linji Li
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Fukai Xie
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Lu Yang
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Maosheng Cheng
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Bin Lin
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Yongxiang Liu
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| |
Collapse
|
19
|
|
20
|
Liang G, Ji Y, Liu H, Pang Y, Zhou B, Cheng M, Liu Y, Lin B, Liu Y. Silver Triflate/
N
‐Fluorobenzenesulfonimide‐Catalyzed Cycloisomerization of Tryptamine‐Ynamide to Spiro[indoline‐3,4′‐piperidine] Induced by Cation‐π‐π Interactions between Substrate and Metal Ligand. Adv Synth Catal 2019. [DOI: 10.1002/adsc.201901175] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Affiliation(s)
- Guoduan Liang
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)Ministry of Education Shenyang 110016 People's Republic of China
- Wuya College of InnovationShenyang Pharmaceutical University Shenyang 110016 People's Republic of China
- Institute of Drug Research inMedicine Capital of China Benxi 117000 People's Republic of China
| | - Yanjun Ji
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)Ministry of Education Shenyang 110016 People's Republic of China
- Institute of Drug Research inMedicine Capital of China Benxi 117000 People's Republic of China
| | - Hairui Liu
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)Ministry of Education Shenyang 110016 People's Republic of China
- Wuya College of InnovationShenyang Pharmaceutical University Shenyang 110016 People's Republic of China
- Institute of Drug Research inMedicine Capital of China Benxi 117000 People's Republic of China
| | - Yadong Pang
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)Ministry of Education Shenyang 110016 People's Republic of China
- Wuya College of InnovationShenyang Pharmaceutical University Shenyang 110016 People's Republic of China
- Institute of Drug Research inMedicine Capital of China Benxi 117000 People's Republic of China
| | - Bojun Zhou
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)Ministry of Education Shenyang 110016 People's Republic of China
- Wuya College of InnovationShenyang Pharmaceutical University Shenyang 110016 People's Republic of China
- Institute of Drug Research inMedicine Capital of China Benxi 117000 People's Republic of China
| | - Maosheng Cheng
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)Ministry of Education Shenyang 110016 People's Republic of China
- Institute of Drug Research inMedicine Capital of China Benxi 117000 People's Republic of China
| | - Yang Liu
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)Ministry of Education Shenyang 110016 People's Republic of China
| | - Bin Lin
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)Ministry of Education Shenyang 110016 People's Republic of China
- Institute of Drug Research inMedicine Capital of China Benxi 117000 People's Republic of China
| | - Yongxiang Liu
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)Ministry of Education Shenyang 110016 People's Republic of China
- Wuya College of InnovationShenyang Pharmaceutical University Shenyang 110016 People's Republic of China
- Institute of Drug Research inMedicine Capital of China Benxi 117000 People's Republic of China
| |
Collapse
|
21
|
Liu C, Sun Z, Xie F, Liang G, Yang L, Li Y, Cheng M, Lin B, Liu Y. Gold(i)-catalyzed pathway-switchable tandem cycloisomerizations to indolizino[8,7-b]indole and indolo[2,3-a]quinolizine derivatives. Chem Commun (Camb) 2019; 55:14418-14421. [DOI: 10.1039/c9cc05667j] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
A common strategy was developed to access both indolizino[8,7-b]indole and indolo[2,3-a]quinolizine derivatives from tryptamine-N-ethynylpropiolamide substrates in a switchable fashion via tuning both the electronic effects and steric effects.
Collapse
Affiliation(s)
- Chengjun Liu
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)
- Ministry of Education
- Shenyang 110016
- P. R. China
- Wuya College of Innovation
| | - Zenghui Sun
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)
- Ministry of Education
- Shenyang 110016
- P. R. China
- Wuya College of Innovation
| | - Fukai Xie
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)
- Ministry of Education
- Shenyang 110016
- P. R. China
- Wuya College of Innovation
| | - Guoduan Liang
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)
- Ministry of Education
- Shenyang 110016
- P. R. China
- Wuya College of Innovation
| | - Lu Yang
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)
- Ministry of Education
- Shenyang 110016
- P. R. China
- Institute of Drug Research in Medicine Capital of China
| | - Yaqiao Li
- College of Chemistry
- Jilin University
- Changchun
- P. R. China
| | - Maosheng Cheng
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)
- Ministry of Education
- Shenyang 110016
- P. R. China
- Institute of Drug Research in Medicine Capital of China
| | - Bin Lin
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)
- Ministry of Education
- Shenyang 110016
- P. R. China
- Institute of Drug Research in Medicine Capital of China
| | - Yongxiang Liu
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)
- Ministry of Education
- Shenyang 110016
- P. R. China
- Wuya College of Innovation
| |
Collapse
|